Hydroxychloroquine-induced podocytopathy mimicking Fabry disease

Hydroxychloroquine (HCQ) is largely prescribed as an immunomodulator to prevent systemic diseases flares in patients with systemic lupus erythematous, rheumatoid arthritis, Sjogren’s disease. Among reported side effects, HCQ can accumulate in lysosomes and induced phospholipidosis. Here, we report a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMJ Case Rep
Hauptverfasser: Serre, Justine, Buob, David, Boffa, Jean-Jacques
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMJ Publishing Group 2019
Schlagworte:
Findings That Shed New Light on the Possible Pathogenesis of a Disease or an Adverse Effect
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6536225/
https://ncbi.nlm.nih.gov/pubmed/31088818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-228876
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge